Dr. Dellamano, also founder and President of ValueVector, was Head of Strategic Pricing at the global Headquarters of the Swiss pharmaceutical giant Hoffmann-La Roche from 1996 to 2003. Before heading the Strategic Pricing function at Hoffmann-La Roche, Dr. Dellamano served as Global Controller of the Pharma Division of the same company. He has also held senior managerial positions at the Italian affiliate of Roche, where he headed the Strategic Planning, Business Development, and Pricing and Reimbursement functions.
A health economist and former professor of hospital management, Dr. Dellamano combines a solid methodological background with extensive global and local business experience in the areas of strategic planning, business development, pharmaceutical pricing, reimbursement, and health economics.
